tiprankstipranks
Embry Holdings Limited (HK:1388)
:1388
Hong Kong Market
Want to see HK:1388 full AI Analyst Report?

Embry Holdings Limited (1388) Price & Analysis

0 Followers

1388 Stock Chart & Stats

HK$0.40
HK$0.02(4.35%)
At close: 4:00 PM EST
HK$0.40
HK$0.02(4.35%)

Bulls Say, Bears Say

Bulls Say
High Gross MarginsGross margins near 70–75% indicate strong product economics and pricing power in its lingerie business. This durable margin buffer supports gross profit even with sales variability, giving management scope to absorb input cost swings and target operating leverage improvements over several months.
Manageable LeverageDebt-to-equity around 0.16–0.31 shows the group is not heavily debt-funded. That manageable leverage preserves financial flexibility to fund working capital, invest in brands or execute restructuring, and reduces near-term solvency risk compared with highly leveraged peers.
Relatively Stable Revenue BaseRevenue has been broadly stable with a modest rebound in 2025, reflecting sustained demand for core apparel lines across channels. A stable top line provides a foundation for operational fixes and potential margin recovery if fixed costs and operating efficiency are addressed over the coming months.
Bears Say
Persistent Operating And Net LossesConsistent operating and net losses (net margin about -22% in 2025) indicate the business is not covering operating expenses despite strong gross profit. This structural unprofitability erodes retained earnings and requires sustained cost cuts or strategic change to restore long-term viability.
Negative Operating And Free Cash FlowOperating cash flow and free cash flow turned negative in 2024 and stayed negative in 2025 (OCF -26.6M; FCF -37.2M), showing material deterioration in cash generation. This constrains the company's ability to reinvest, raises liquidity needs, and increases reliance on external funding over the medium term.
Erosion Of Equity And Negative ROEEquity has fallen materially from 2.52B in 2021 to 1.55B in 2025 while ROE is around -16% in 2025, signaling capital erosion. Declining equity reduces financial buffers, heightens the probability of future capital raises, and indicates the company is currently destroying shareholder value.

Embry Holdings Limited News

1388 FAQ

What was Embry Holdings Limited’s price range in the past 12 months?
Embry Holdings Limited lowest stock price was HK$0.28 and its highest was HK$0.60 in the past 12 months.
    What is Embry Holdings Limited’s market cap?
    Embry Holdings Limited’s market cap is HK$118.28M.
      When is Embry Holdings Limited’s upcoming earnings report date?
      Embry Holdings Limited’s upcoming earnings report date is Aug 20, 2026 which is in 62 days.
        How were Embry Holdings Limited’s earnings last quarter?
        Embry Holdings Limited released its earnings results on Mar 27, 2026. The company reported -HK$0.462 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.462.
          Is Embry Holdings Limited overvalued?
          According to Wall Street analysts Embry Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Embry Holdings Limited pay dividends?
            Embry Holdings Limited pays a Quarterly dividend of HK$0.02 which represents an annual dividend yield of N/A. See more information on Embry Holdings Limited dividends here
              What is Embry Holdings Limited’s EPS estimate?
              Embry Holdings Limited’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Embry Holdings Limited have?
              Embry Holdings Limited has 422,416,630 shares outstanding.
                What happened to Embry Holdings Limited’s price movement after its last earnings report?
                Embry Holdings Limited reported an EPS of -HK$0.462 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.389%.
                  Which hedge fund is a major shareholder of Embry Holdings Limited?
                  Currently, no hedge funds are holding shares in HK:1388
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Embry Holdings Limited

                    Embry Holdings Limited operates as an investment holding company primarily focused on the entire lifecycle of women's intimate apparel, encompassing design, research, development, manufacturing, and distribution. Its product offerings include brassieres, panties, swimwear, and sleepwear, marketed under a portfolio of established brands such as EMBRY FORM, FANDECIE, COMFIT, E-BRA, IVU, IADORE, and LIZA CHENG. Beyond its core apparel business, the company also manages a collection of trademarks and holds property investments. As of December 31, 2021, it maintained a substantial retail network of 1,251 points of sale, consisting of 1,049 concessionary counters and 202 standalone stores, spread across Mainland China, Hong Kong, and Macau. An online retail platform complements its physical presence. Founded in 1975 and headquartered in Kwai Chung, Hong Kong, Embry Holdings Limited is a subsidiary of Harmonious World Limited.

                    Embry Holdings Limited (1388) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Shenzhou International Group Holdings
                    Luen Thai Holdings Limited
                    Win Hanverky Holdings Limited
                    Regina Miracle International (Holdings) Limited
                    Cosmo Lady (China) Holdings Co. Ltd.
                    Popular Stocks